Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Bi-compartmental CSF–serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
CSF Beta-Synuclein, SNAP-25, and Neurogranin in infectious and autoimmune inflammatory neurologic diseases
10.1212/nxi.0000000000200491 · 2025 · External reference
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
10.1093/brain/awy154 · 2018 · External reference
Diagnostic value of cerebrospinal fluid Neurofilament light protein in neurology: a systematic review and Meta-analysis
10.1001/jamaneurol.2019.1534 · 2019 · External reference
Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis
10.1111/j.1468-1331.1999.tb00010.x · 1999 · External reference
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
10.1038/s41598-020-79800-2 · 2020 · External reference
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
10.1023/a:1007677003387 · 2000 · External reference
CXCL13 in cerebrospinal fluid: clinical value in a large cross-sectional study
10.3390/ijms25010425 · 2023 · External reference
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays
10.1515/cclm-2023-1256 · 2024 · External reference
Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament-light chain in multiple sclerosis
10.1002/acn3.51355 · 2021 · External reference
Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010
10.1371/journal.pone.0104169 · 2014 · External reference
Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment
10.1016/s1474-4422(09)70134-6 · 2009 · External reference
Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
10.1186/s13195-018-0364-0 · 2018 · External reference
Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections
10.1007/s00415-013-6883-5 · 2013 · External reference
Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS
10.1136/jnnp-2021-327129 · 2022 · External reference
Age-specific control and Alzheimer disease reference curves and z-scores for glial fibrillary acidic protein in blood
10.1093/clinchem/hvaf120 · 2025 · External reference
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases
10.1007/s00415-025-13271-1 · 2025 · External reference
Beyond the GFAP-astrocyte protein markers in the brain
10.3390/biom11091361 · 2021 · External reference
Neurofilaments as biomarkers in neurological disorders
10.1038/s41582-018-0058-z · 2018 · External reference
Outcome and sequelae of infectious encephalitis
10.3988/jcn.2023.0240 · 2024 · External reference
CXCL11 production in cerebrospinal fluid distinguishes herpes simplex meningitis from herpes simplex encephalitis
10.1186/s12974-017-0907-5 · 2017 · External reference
Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus
10.1186/s12974-019-1428-1 · 2019 · External reference
Ella versus Simoa serum Neurofilament assessment to monitor treatment response in highly active multiple sclerosis patients
10.3390/ijms232012361 · 2022 · External reference
Varicella-zoster virus CNS disease—viral load, clinical manifestations and sequels
10.1016/j.jcv.2009.07.014 · 2009 · External reference
Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection
10.1002/mus.21448 · 2010 · External reference
Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study
10.1186/s12974-019-1405-8 · 2019 · External reference
Comparative analysis of SiMoA and Ella immunoassay platforms for measuring serum Neurofilament light chain levels in ATTRv with polyneuropathy and Presymptomatic carriers
10.1111/ene.70215 · 2025 · External reference
Flow rate of cerebrospinal fluid (CSF)—a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases
10.1016/0022-510x(94)90298-4 · 1994 · External reference
Cerebrospinal fluid—physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases
1998 · External reference
The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis
10.1177/135245859800400304 · 1998 · External reference
Acute and chronic polyradiculopathies
10.1212/01.con.0000403798.87740.cc · 2011 · External reference
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
2016 · External reference
Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction
10.1007/s004150070134 · 2000 · External reference
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias
10.1016/j.mcpro.2023.100629 · 2023 · External reference
Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study
10.1038/s41598-023-29704-8 · 2023 · External reference
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
2020 · External reference
NfL (Neurofilament light chain) levels as a predictive marker for long-term outcome after ischemic stroke
10.1161/strokeaha.119.026410 · 2019 · External reference
Levels and age dependency of Neurofilament light and glial fibrillary acidic protein in healthy individuals and their relation to the brain parenchymal fraction
10.1371/journal.pone.0135886 · 2015 · External reference
Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients
10.1111/ene.15978 · 2023 · External reference
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium
10.1093/cid/cit458 · 2013 · External reference
Acute encephalitis in immunocompetent adults
10.1016/s0140-6736(18)32526-1 · 2019 · External reference
Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis
10.1016/j.cmi.2020.09.031 · 2021 · External reference